Promoter and Public shareholding in Biofil Chemicals declined both YoY and QoQ, indicating a lack of confidence from both insiders and retail investors.

Institutional shareholding remained stagnant, aligning with sector averages where no significant changes were observed.

In comparison to sector performers, Biofil's declining shareholding contrasts sharply with best performers like SUDARSHAN, which saw significant institutional buying.